Fibrinogen is a clotting protein that helps blood form a stable clot after an injury. It is also called factor I and is made mainly by the liver. A fibrinogen blood test checks how much working fibrinogen is present in the blood, usually as part of an evaluation for unusual bleeding, suspected disseminated intravascular coagulation (DIC), liver disease, major trauma, pregnancy-related bleeding, or inherited clotting disorders.
For most adults, a typical fibrinogen reference range is about 200–400 mg/dL, also written as 2.0–4.0 g/L. Results below the range raise concern for reduced clot strength and bleeding risk, especially when levels fall sharply or occur with prolonged PT, prolonged aPTT, low platelets, or active bleeding. Results above the range usually reflect inflammation, infection, pregnancy, estrogen exposure, smoking, tissue injury, or chronic disease rather than a primary clotting disorder by themselves.
- A normal adult fibrinogen result is usually 200–400 mg/dL, but the lab’s own reference interval should guide interpretation.
- Low fibrinogen means the blood has less factor I available to build a firm fibrin clot.
- High fibrinogen most often reflects inflammation or an acute-phase response, not “thick blood” by itself.
- Fibrinogen is usually tested from a sodium citrate plasma sample drawn in a blue-top tube.
- Urgent follow-up matters when low fibrinogen appears with active bleeding, pregnancy bleeding, trauma, sepsis, DIC, or severe liver disease.
- Fibrinogen results are best read with PT, INR, aPTT, platelet count, D-dimer, thrombin time, and the clinical situation.
Table of Contents
- What the Fibrinogen Test Measures
- Normal Fibrinogen Range
- Low Fibrinogen Results
- High Fibrinogen Results
- How Results Are Interpreted With Other Tests
- Pregnancy, Surgery, and Emergency Settings
- Test Preparation and Sample Issues
- What to Do After an Abnormal Result
What the Fibrinogen Test Measures
A fibrinogen blood test measures factor I, a blood protein that turns into fibrin during clot formation. Fibrin forms the mesh that strengthens a clot after platelets gather at the site of injury. Without enough fibrinogen, a clot forms poorly, breaks down too easily, or fails to stop bleeding.
The most common fibrinogen test is a functional fibrinogen activity test. It checks how well fibrinogen works, not only how much fibrinogen is present. In many laboratories, this is a Clauss fibrinogen assay. The test adds thrombin to diluted plasma and measures how quickly a fibrin clot forms. Faster clot formation generally means more functional fibrinogen; slower clot formation suggests less working fibrinogen or interference with clot formation.
Fibrinogen is also an acute-phase reactant. That means the liver raises fibrinogen production during inflammation, infection, tissue injury, pregnancy, and some chronic illnesses. This dual role makes fibrinogen different from many other clotting factors. A low result often points toward bleeding risk or fibrinogen consumption, while a high result often points toward inflammation or a pro-clotting background state.
Fibrinogen testing is commonly ordered when a person has:
- Unexplained easy bruising or bleeding
- Heavy bleeding after surgery, childbirth, injury, or dental work
- Suspected DIC, where clotting and bleeding happen at the same time
- Abnormal results on PT, INR, aPTT, thrombin time, or reptilase time
- Severe liver disease or suspected reduced clotting factor production
- A family history of rare fibrinogen disorders
- Monitoring during massive transfusion, trauma care, or obstetric hemorrhage
Fibrinogen is rarely interpreted alone. A clinician usually reads it with the broader coagulation panel, the person’s symptoms, medications, pregnancy status, liver function, and signs of inflammation or infection.
Normal Fibrinogen Range
A typical adult fibrinogen reference range is 200–400 mg/dL. The same range is often reported as 2.0–4.0 g/L. Some laboratories use slightly different intervals because of differences in instruments, reagents, assay method, specimen handling, and the population used to establish the reference range.
| Fibrinogen result | Approximate equivalent | Common meaning |
|---|---|---|
| Below 100 mg/dL | Below 1.0 g/L | Very low; bleeding risk rises, especially with symptoms or other abnormal clotting tests |
| 100–199 mg/dL | 1.0–1.99 g/L | Low; suggests reduced fibrinogen, consumption, liver production problems, or fibrinolysis |
| 200–400 mg/dL | 2.0–4.0 g/L | Typical adult reference range in many laboratories |
| Above 400 mg/dL | Above 4.0 g/L | High; often seen with inflammation, infection, pregnancy, estrogen therapy, smoking, or chronic disease |
The word “normal” needs context. A fibrinogen level of 250 mg/dL fits many adult reference ranges, but it is not reassuring in every situation. During late pregnancy, fibrinogen levels normally rise much higher than nonpregnant adult levels, often near or above 400–500 mg/dL. In that setting, a result around 250 mg/dL during heavy bleeding is concerning even though it overlaps with a usual nonpregnant adult range.
A result of 390 mg/dL is also not automatically a problem. It sits near the upper end of many reference intervals and often appears during minor inflammation, recovery from injury, or pregnancy. A persistent result above the lab range needs clinical review, especially when other inflammation markers or cardiovascular risk factors are present.
Fibrinogen units matter. To convert g/L to mg/dL, multiply by 100. A result of 3.2 g/L equals 320 mg/dL. To convert mg/dL to g/L, divide by 100. A result of 180 mg/dL equals 1.8 g/L.
Low Fibrinogen Results
Low fibrinogen means the blood has less working factor I available to form a stable fibrin clot. The lower the level, the more important the clinical setting becomes. A mildly low result in a stable person without bleeding has a different meaning from a rapidly falling result in trauma, childbirth, sepsis, or DIC.
Low fibrinogen has two broad patterns: the body does not have enough fibrinogen, or the fibrinogen present does not work properly. A functional activity test detects many problems with working fibrinogen, but additional tests are sometimes needed to separate low quantity from poor function.
Common causes of low fibrinogen include:
- DIC, where clotting factors and platelets are consumed faster than the body replaces them
- Severe liver disease, because the liver produces fibrinogen
- Major bleeding or massive transfusion
- Excess fibrinolysis, where clots and fibrinogen break down too quickly
- Thrombolytic medications used to dissolve clots
- Rare inherited fibrinogen deficiency
- Some cancer therapies, including L-asparaginase
- Severe obstetric bleeding, placental abruption, or amniotic fluid embolism
Inherited fibrinogen disorders are uncommon but important. Afibrinogenemia means fibrinogen is absent or nearly absent. Hypofibrinogenemia means fibrinogen is reduced. Dysfibrinogenemia means the fibrinogen level by antigen testing is normal or near normal, but the fibrinogen does not function normally. Hypodysfibrinogenemia combines low amount and poor function.
Symptoms of clinically important low fibrinogen include prolonged bleeding from cuts, frequent nosebleeds, heavy menstrual bleeding, bleeding after surgery or dental work, deep bruising, joint or muscle bleeding, postpartum hemorrhage, or bleeding from multiple sites during severe illness. Some inherited fibrinogen disorders also raise clot risk, so a history of thrombosis does not rule out a fibrinogen problem.
Low fibrinogen is especially concerning when it appears with a high D-dimer result, low platelet count, prolonged PT/INR, prolonged aPTT, or signs of organ dysfunction. That pattern fits consumption or breakdown of clotting factors, which needs prompt medical evaluation.
High Fibrinogen Results
High fibrinogen usually means the liver is producing more fibrinogen in response to inflammation, hormones, tissue injury, or chronic disease. It does not diagnose a blood clot by itself. It also does not prove that the blood is dangerously “thick.” Instead, it adds one piece of information about the body’s inflammatory and clotting environment.
Common causes of high fibrinogen include:
- Acute infection
- Chronic inflammatory disease
- Recent surgery, injury, burns, or tissue damage
- Pregnancy
- Estrogen therapy or some oral contraceptives
- Smoking
- Obesity and metabolic inflammation
- Nephrotic syndrome
- Some cancers
- Compensated clotting activation, where fibrinogen rises before it becomes depleted
A high fibrinogen result often travels with other inflammation findings, such as a high C-reactive protein, high erythrocyte sedimentation rate, high white blood cell count, or high ferritin from inflammation. In that setting, fibrinogen acts more like an inflammation marker than a stand-alone clotting diagnosis.
Persistently high fibrinogen has been associated with increased cardiovascular and thrombotic risk in population studies. The result is not used like LDL cholesterol or blood pressure, and it does not replace standard cardiovascular risk assessment. A high value becomes more meaningful when it appears with smoking, diabetes, high blood pressure, high LDL cholesterol, high triglycerides, obesity, chronic kidney disease, inflammatory disease, or a personal history of blood clots.
High fibrinogen can also affect other coagulation tests. In some settings, very high fibrinogen shortens certain clotting times and complicates interpretation of lupus anticoagulant testing. This is one reason clinicians avoid reading a single coagulation result in isolation. When antiphospholipid syndrome is part of the concern, fibrinogen is read with the antiphospholipid antibody panel and the person’s clotting or pregnancy history.
A single high result during an illness often falls after recovery. Persistent elevation deserves a broader search for inflammation, infection, smoking exposure, metabolic risk, kidney disease, autoimmune disease, or malignancy when symptoms or other tests point that way.
How Results Are Interpreted With Other Tests
Fibrinogen results become clearer when compared with other clotting tests. The pattern matters more than one number. For example, low fibrinogen with prolonged PT, prolonged aPTT, low platelets, and high D-dimer suggests a very different problem from isolated high fibrinogen with normal clotting times.
| Test | What it adds | Helpful pattern |
|---|---|---|
| PT and INR | Checks the extrinsic and common clotting pathways | Prolonged PT/INR plus low fibrinogen raises concern for liver disease, DIC, vitamin K-related problems, or major factor loss |
| aPTT or PTT | Checks the intrinsic and common clotting pathways | Prolonged aPTT plus low fibrinogen suggests common pathway involvement, DIC, severe factor deficiency, or anticoagulant effect |
| Platelet count | Shows whether enough platelets are available for the first stage of clotting | Low platelets plus low fibrinogen fits consumption, severe illness, or massive bleeding patterns |
| D-dimer or FDP | Shows clot breakdown activity | High D-dimer plus falling fibrinogen raises concern for DIC or active fibrinolysis |
| Thrombin time | Checks conversion of fibrinogen to fibrin | Prolonged thrombin time points toward fibrinogen problems, heparin effect, direct thrombin inhibitors, or fibrin breakdown products |
| Reptilase time | Checks fibrin formation without heparin interference | Prolonged reptilase time supports fibrinogen abnormality when thrombin time is prolonged |
PT and INR are often ordered when liver disease, warfarin effect, vitamin K deficiency, or DIC is possible. A prolonged prothrombin time test with low fibrinogen needs closer review because both abnormalities involve clot formation.
The aPTT looks at a different part of the clotting system. A prolonged aPTT result with low fibrinogen often points toward a broader clotting problem rather than an isolated fibrinogen issue.
Thrombin time and reptilase time help separate fibrinogen problems from some medication effects. A prolonged thrombin time test occurs when fibrin formation is delayed. If thrombin time is prolonged but reptilase time is normal, heparin or a direct thrombin inhibitor becomes more likely. If both are prolonged, a fibrinogen quantity or function problem becomes more likely.
Fibrinogen antigen testing measures the amount of fibrinogen protein, while fibrinogen activity measures function. When activity is low but antigen is normal or less reduced, dysfibrinogenemia becomes a consideration. This difference helps explain why a person with a rare fibrinogen disorder might have a misleadingly acceptable amount of fibrinogen but still form abnormal clots.
Pregnancy, Surgery, and Emergency Settings
Pregnancy changes fibrinogen interpretation because fibrinogen normally rises as pregnancy progresses. A result that looks “normal” by nonpregnant adult standards can be too low for late pregnancy, especially during heavy bleeding. Obstetric teams treat falling fibrinogen as an important warning sign in postpartum hemorrhage, placental abruption, amniotic fluid embolism, and severe DIC.
In late pregnancy, fibrinogen often reaches levels around 400–500 mg/dL or higher. During major obstetric bleeding, a level below 300 mg/dL deserves close attention, and levels near or below 200 mg/dL are strongly concerning in many emergency settings. The exact treatment threshold depends on local protocols, bleeding severity, viscoelastic testing, blood product availability, and the full coagulation picture.
Surgery and trauma also change the meaning of fibrinogen. During major bleeding, fibrinogen is often one of the first clotting factors to fall to critically low levels. Dilution from IV fluids and transfused red blood cells, consumption at injury sites, and fibrinolysis all contribute. In these settings, clinicians monitor fibrinogen to decide whether fibrinogen replacement is needed through cryoprecipitate or fibrinogen concentrate.
DIC is another high-risk setting. In DIC, widespread clotting activation consumes platelets and clotting factors. The person can develop clots in small vessels while also bleeding because the clotting system becomes depleted. Low or falling fibrinogen is one part of that pattern, especially when D-dimer is high, platelets are low, and PT or aPTT is prolonged. The FDP test sometimes helps show increased clot breakdown when DIC or fibrinolysis is being evaluated.
Liver disease deserves separate attention. The liver makes fibrinogen, but liver disease can produce mixed clotting findings. Some people with chronic liver disease have low fibrinogen from reduced production. Others have abnormal fibrinogen function or changes in several clotting and anti-clotting proteins at the same time. A hepatic function panel, PT/INR, platelet count, and clinical signs of liver disease help place the fibrinogen result in context.
Test Preparation and Sample Issues
Most people need no special preparation for a fibrinogen blood test. Fasting is not usually required unless other blood tests drawn at the same visit require it. The blood sample is commonly drawn into a blue-top tube containing sodium citrate, an anticoagulant that preserves the sample for clotting studies.
Proper sample handling matters. Coagulation tests are sensitive to blood-to-anticoagulant ratio, tube fill volume, clots in the tube, hemolysis, lipemia, delayed processing, and storage conditions. A tube that is underfilled can distort clotting results. A sample that clots before testing can give unreliable results.
Very high hematocrit, meaning a very high percentage of red blood cells, also matters. When hematocrit is above about 55%, the amount of citrate in the tube often needs adjustment. Without that adjustment, coagulation results can be inaccurate because the plasma-to-citrate ratio is wrong.
Medication history is important. Heparin, direct thrombin inhibitors, thrombolytic drugs, estrogen therapy, oral contraceptives, and some cancer therapies can influence fibrinogen results or related clotting tests. Anticoagulant medications do not all affect fibrinogen the same way, so the clinician and laboratory need to know what the person is taking.
A falsely low functional fibrinogen result can occur when substances interfere with clot formation in the assay. Very high heparin levels, direct thrombin inhibitors, fibrin breakdown products, severe lipemia, or severe hemolysis can affect some methods. When the result does not match the clinical picture, repeating the test or adding antigen testing, thrombin time, reptilase time, or specialized coagulation studies gives a clearer answer.
For suspected rare fibrinogen disorders, testing often goes beyond one fibrinogen activity result. A hematologist may order fibrinogen antigen, thrombin time, reptilase time, genetic testing, family studies, and specialized assays. This deeper workup separates inherited quantitative deficiency from dysfibrinogenemia and acquired abnormalities.
What to Do After an Abnormal Result
An abnormal fibrinogen result needs action based on severity, symptoms, and context. A mildly high result during a respiratory infection usually calls for follow-up after recovery, not emergency treatment. A low result with active bleeding, trauma, pregnancy bleeding, sepsis, or suspected DIC needs urgent medical attention.
Seek urgent care now for abnormal bleeding with any of these symptoms:
- Heavy bleeding that does not slow with pressure
- Vomiting blood or passing black, tarry stool
- Severe headache, confusion, weakness, or fainting with bleeding concern
- Large unexplained bruises or rapidly spreading bruising
- Bleeding during pregnancy or soon after delivery
- Bleeding after surgery, childbirth, injury, or a procedure
- Shortness of breath, chest pain, leg swelling, or sudden neurologic symptoms
For low fibrinogen, follow-up often includes repeating the test, reviewing PT/INR, aPTT, platelet count, D-dimer, liver tests, kidney tests, and medication exposures. If the result is very low or the person is bleeding, treatment focuses on the underlying cause and restoring clotting capacity. Hospital teams use protocols that may include cryoprecipitate, fibrinogen concentrate, plasma, platelets, red blood cells, tranexamic acid, or other targeted therapy depending on the situation.
For high fibrinogen, follow-up usually looks for inflammation and risk factors. A clinician may review recent infection, autoimmune symptoms, smoking, pregnancy status, estrogen therapy, kidney disease, cancer symptoms, and cardiovascular risk. Rechecking fibrinogen after an acute illness has resolved often clarifies whether the elevation was temporary.
Lifestyle changes do not treat a dangerous clotting disorder, but they help when high fibrinogen reflects chronic inflammation or cardiovascular risk. Stopping smoking, treating high blood pressure, improving diabetes control, addressing sleep apnea, reducing excess weight, staying physically active, and treating inflammatory disease can improve the broader risk profile. The result should not be managed as a stand-alone number without the rest of the clinical picture.
People with a personal or family history of unusual bleeding, miscarriages, thrombosis, or known fibrinogen disorders should ask whether hematology referral is appropriate. Rare fibrinogen disorders require careful interpretation because both bleeding and clotting problems can occur. The safest plan comes from matching the lab pattern with the person’s bleeding history, clotting history, pregnancy history, planned procedures, and family history.
References
- Fibrinogen blood test 2025 (Official Health Information)
- International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders 2024 (Guideline)
- Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others 2025 (Guideline)
- Management and outcomes of women with low fibrinogen concentration during pregnancy or immediately postpartum: A UK national population-based cohort study 2024 (Cohort Study)
- 001610: Fibrinogen Activity 2026 (Laboratory Test Information)
- CLFIB – Overview: Fibrinogen, Clauss, Plasma 2026 (Laboratory Test Information)
Disclaimer
This information is educational and does not replace diagnosis, treatment, or interpretation from a qualified healthcare professional. Fibrinogen results need clinical context, especially during bleeding, pregnancy, liver disease, trauma, surgery, anticoagulant use, or suspected DIC. Seek urgent medical care for heavy bleeding, pregnancy-related bleeding, or symptoms that suggest a blood clot or serious illness.
